IPSC Earnings

Quarterly EPS
$-0.37
Q3 2024
$-0.42
Q4 2024
$0.89
Q1 2025
$-0.38
Q2 2025
$-0.40
Q3 2025
$-0.22
Q4 2025
$-0.11
Q1 2026
$-0.17
Q2 2026
Latest RevenueN/A
Latest Net Income-34550000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.170-34550000+55.3%
Q1 2026-$0.110-21645000-100.0%-112.4%
Q4 2025-$0.220-19171000-100.0%+47.6%
Q3 2025-$0.400-34422000-100.0%-8.1%
Q2 2025-$0.380-32541000-100.0%+0.0%
Q1 2025$0.89109.2M76.6M+12,667.7%+297.8%
Q4 2024-$0.424.2M-36073000+1,457.1%+36.4%
Q3 2024-$0.37791.0K-31226000+434.5%+32.7%
Q2 2024-$0.38771.0K-31207000
Q1 2024-$0.45855.0K-28062000
Q4 2023-$0.66268.0K-39398000
Q3 2023-$0.55148.0K-32720000
Century Therapeutics (IPSC) — Earnings